Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$19.95 - $31.0 $798 - $1,240
-40 Reduced 2.12%
1,850 $53,000
Q2 2023

Aug 14, 2023

SELL
$34.33 - $62.11 $1.64 Million - $2.97 Million
-47,840 Reduced 96.2%
1,890 $108,000
Q1 2023

May 11, 2023

BUY
$26.01 - $48.69 $1.29 Million - $2.42 Million
49,730 New
49,730 $1.87 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Industrial Alliance Investment Management Inc. Portfolio

Follow Industrial Alliance Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Industrial Alliance Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Industrial Alliance Investment Management Inc. with notifications on news.